2010-10-19

[DIV28SUPER] Fwd: NIDA Neuroscience Update, October 20, 2010



Sent from my iPhone

Begin forwarded message:

From: "NIDA NEURO SCIENCE (NIH/NIDA)" <nidaneurosc@MAIL.NIH.GOV>
Date: October 19, 2010 11:20:32 PM EDT
To: "NIDA_NEURO_SCIENCE-L@LIST.NIH.GOV" <NIDA_NEURO_SCIENCE-L@LIST.NIH.GOV>
Subject: NIDA Neuroscience Update, October 20, 2010
Reply-To: "NIDA NEURO SCIENCE (NIH/NIDA)" <nidaneurosc@MAIL.NIH.GOV>

 

Table of Contents

 

I.   Last Call to Register: NIDA/SfN Mini-Convention: Frontiers in Addiction Research

 

II.  NIDA Encourages NIDA funded PIs to identify NIDA supported graduate students for nomination to attend 61st annual meeting of Nobel Laureates in Lindau, Germany

 

III.  RFA: Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21)

 

IV.  Neuroscience Research on Drug Abuse PA

------

 

 

I.  Last Call to Register:  NIDA/SfN Mini-Convention: Frontiers in Addiction Research

Date & Time: Friday, November 12, 8:00 AM - 6:20 PM
Location: San Diego Marriott Hotel and Marina
Room: Marriott Hall

Online registration: www.seiservices.com/nida/frontiers2010/ 

Online registration closes October 29- space is limited

 

The National Institute on Drug Abuse (NIDA) Mini-Convention, Frontiers in Addiction Research, will feature cutting-edge presentations and discussion of future directions in the neurobiology of drug abuse and addiction. The NIDA Mini-Convention includes four symposia, the SfN Jacob Waletzky Memorial Lecture and a poster session featuring early career investigators.

 

II. NIDA Encourages NIDA funded PIs to identify NIDA supported graduate students for nomination to attend 61st annual meeting of Nobel Laureates in Lindau, Germany

The Department of Energy (DOE) and the National Institutes of Health (NIH) are pleased to announce that they will nominate and sponsor a maximum of 55 graduate students to attend the 61st annual meeting of Nobel Laureates and students in Lindau, Germany, from June 26 through July 1, 2011. This year, we are increasing the number of applications accepted by the sponsors.   We invite your institution to nominate up to two students for each sponsor to be considered for this very exciting opportunity. 

 

All nominations must be submitted online before Monday, November 1, 2010 at 4:00 pm, Eastern Time.  Nominees will be notified by December 1, 2010 whether they have been selected. An information sheet on the program is enclosed. Further information about the program, including the Web site for submission of nominations, can be found online beginning on October 1, 2010 at http://www.orau.org/lindau/.

 

Since 1951, Nobel Prize winners and students in chemistry, physics, and physiology or medicine have met annually in Lindau, located on Lake Constance in southwestern Germany. It is anticipated that some 550 students from more than 70 countries will attend the weeklong meeting in 2011. There are formal lectures in the morning, and the remainder of the day is set aside for the students to meet informally with the Nobel Laureate scientists, as well as with their fellow students from around the world. Information on the most recent meeting and comments from students who attended are available at http://www.orau.org/lindau/past-mtgs/default.shtml.

 

In 2011, the meeting will feature recipients of the Nobel Prize in Physiology or Medicine. You may nominate students to attend this meeting who:

 

·         are U.S. citizens currently enrolled at a university as full-time graduate students;

·         have completed by June 2011 at least two years of graduate studies and not more than four years in physiology, medicine, or in a related field, including the basic biomedical (or life) sciences;

·         be supported by and/or working on a project, grant, or fellowship sponsored by the Department of Energy Office of Science (DOE-SC) or the National Institutes of Health (NIH).

 

We are especially interested in receiving nominations from a diverse group of students, including women, minorities and people with disabilities.

 

DOE and NIH will again partner this year with ORAU and Mars, Incorporated.  Those organizations are separately announcing their nomination processes, but will also accept two nominations as well. 

 

The selection process for the Lindau Meeting occurs over three phases.  The universities and National Laboratories complete the first phase by selecting two students per sponsor and submitting the nomination packet for each student.  DOE and NIH complete phase two by selecting the students to nominate to the Lindau Meeting.  The final phase of selection is completed by the Lindau Meeting and its screening process. All three phases ultimately adhere to the Lindau Meeting's selection criteria, which is attached with this e-mail message.

 

All nominations must be submitted online before Monday, November 1, 2010 at 4:00 pm, Eastern Time.  Nominees will be notified by December 1, 2010 whether they have been selected. An information sheet on the program is enclosed. Further information about the program, including the Web site for submission of nominations, can be found online beginning on October 1, 2010 at http://www.orau.org/lindau/.

 

You may delegate responsibility for submitting nominations to another office in your institution.

However, individual faculty members may not submit nominations directly. If you have any questions or need further information, please contact one of us using the contact information below.

 

Best Regards,

 

William J. Valdez                                                                      Michael Rogers

Director, Workforce Development                                 Director, Pharmacology, Physiology, and Biological Chemistry Division

Office of Science                                                                 National Institute of General Medical Sciences

U.S. Department of Energy                                                 National Institutes of Health

865-576-8223 (Sam Held)                                                  301-594-3827

sam.held@orau.org                                                             rogersm@nigms.nih.gov

 

 

 

III. Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21)

Application Due Date(s):  January 18, 2011
Peer Review Date(s): February/March 2011
Council Review Date(s): May 2011
Earliest Anticipated Start Date(s):  July 2011 

URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-007.html

 

Purpose.  This FOA, issued by the National Institute on Drug Abuse (NIDA), requests applications that propose to develop biological assays that will facilitate the discovery of new molecular probes for investigating the biological function of neuronal nicotinic acetylcholine receptors (nAChRs).   Membrane-spanning subunits (alpha and beta) aggregate in pentamers to form various combinations of functional nAChR ion channels.  Genetic association studies have implicated variants in the α5-α3-β4 cholinergic nicotinic receptor subunit gene cluster on chromosome 15q24-25.1 for the risk of nicotine addiction, tobacco dependence, smoking, and lung cancer.  Other studies have implicated the α6-subunit in nicotine addiction.  This FOA seeks applications proposing to develop biological assays for constitutive receptor combinations involving α3, α5, α6, and/or β4 subunits, suitable ultimately for configuration as high throughput screening (HTS) assays. 

Mechanism of Support. The NIH Exploratory/Developmental (R21) with modifications.

Funds Available and Anticipated Number of Awards.  Approximately $1.5 million will be available. NIDA anticipates making approximately 5-7 awards in 2011..

Budget and Project Period:  The total project period for an application submitted in response to this funding opportunity may not exceed one year.  Direct costs are limited to $150,000.  

 

 

IV. Title:  Neuroscience Research on Drug Abuse PA

Application Due Dates:  see http://grants.nih.gov/grants/funding/submissionschedule.htm

Purpose: This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages Research applications from institutions/ organizations that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans.  See PA for more details: http://grants.nih.gov/grants/guide/pa-files/PA-10-268.html (R01); http://grants.nih.gov/grants/guide/pa-files/PA-10-269.html (R21); http://grants.nih.gov/grants/guide/pa-files/PA-10-270.html (R03).

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

 

http://list.nih.gov/cgi-bin/wa?SUBED1=nida_neuro_science-l&A=1&X=6F4BAE4CF706755A29&Y=nidaneurosc%40mail.nih.gov&A=0

No comments:

Post a Comment